Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00141427|
Recruitment Status : Completed
First Posted : September 1, 2005
Last Update Posted : March 25, 2008
|Condition or disease||Intervention/treatment||Phase|
|Seizures||Drug: Pregabalin||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||540 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial|
|Study Start Date :||November 2004|
|Actual Study Completion Date :||May 2006|
- Reduction in seizure frequency.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00141427
Show 56 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|